6.46
price up icon3.19%   0.20
after-market Handel nachbörslich: 6.59 0.13 +2.01%
loading
Schlusskurs vom Vortag:
$6.26
Offen:
$6.29
24-Stunden-Volumen:
198.07K
Relative Volume:
0.68
Marktkapitalisierung:
$411.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-76.41M
KGV:
-3.3646
EPS:
-1.92
Netto-Cashflow:
$-64.56M
1W Leistung:
-1.67%
1M Leistung:
+4.87%
6M Leistung:
-21.79%
1J Leistung:
-9.65%
1-Tages-Spanne:
Value
$6.1978
$6.72
1-Wochen-Bereich:
Value
$6.0636
$6.72
52-Wochen-Spanne:
Value
$4.345
$12.38

Aura Biosciences Inc Stock (AURA) Company Profile

Name
Firmenname
Aura Biosciences Inc
Name
Telefon
(617)500-8864
Name
Adresse
80 GUEST STREET, BOSTON
Name
Mitarbeiter
106
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-24
Name
Neueste SEC-Einreichungen
Name
AURA's Discussions on Twitter

Vergleichen Sie AURA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AURA
Aura Biosciences Inc
6.46 411.09M 0 -76.41M -64.56M -1.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-28 Fortgesetzt H.C. Wainwright Buy
2024-07-25 Eingeleitet H.C. Wainwright Buy
2023-07-27 Eingeleitet Scotiabank Sector Outperform
2023-04-17 Fortgesetzt BTIG Research Buy
2022-07-19 Eingeleitet JMP Securities Mkt Outperform

Aura Biosciences Inc Aktie (AURA) Neueste Nachrichten

pulisher
Jun 18, 2025

Aura Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 16, 2025

Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Harbor Capital Advisors Inc. Takes Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

PTC Brings Cloud-Native Model-Based Definition to Onshape - The Globe and Mail

Jun 13, 2025
pulisher
Jun 13, 2025

Company News for Jun 13, 2025 - The Globe and Mail

Jun 13, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Increases Stock Holdings in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Reduces Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail

Jun 11, 2025
pulisher
Jun 10, 2025

Kernaghan buying at Western Forest Products (WEF) - The Globe and Mail

Jun 10, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Invests $50,000 in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

15,427 Shares in Aura Biosciences, Inc. (NASDAQ:AURA) Acquired by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Has $704,000 Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Option Volatility And Earnings Report For June 26 - The Globe and Mail

Jun 02, 2025
pulisher
May 31, 2025

Learn to Evaluate (AURA) using the Charts - news.stocktradersdaily.com

May 31, 2025
pulisher
May 31, 2025

Brokers Set Expectations for AURA Q2 Earnings - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Buys 15,951 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

May 31, 2025
pulisher
May 31, 2025

Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 31, 2025
pulisher
May 30, 2025

Equities Analysts Offer Predictions for AURA FY2028 Earnings - Defense World

May 30, 2025
pulisher
May 29, 2025

Aura Biosciences (NASDAQ:AURA) Raised to Buy at HC Wainwright - Defense World

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright sets $22 target for Aura Biosciences stock By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 29, 2025

Aura Biosciences (AURA) Receives 'Buy' Rating from HC Wainwright & Co. | AURA Stock News - GuruFocus

May 29, 2025
pulisher
May 28, 2025

H.C. Wainwright sets $22 target for Aura Biosciences stock - Investing.com

May 28, 2025
pulisher
May 28, 2025

Aura Biosciences assumed with a Buy at H.C. Wainwright - TipRanks

May 28, 2025
pulisher
May 28, 2025

AURA: Analyst Initiates Buy Rating with $22 Price Target | AURA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Innovative Precision Oncology and Promising Clinical Results Justify Buy Rating for Aura Biosciences Inc - TipRanks

May 28, 2025
pulisher
May 25, 2025

Aura Biosciences (NASDAQ:AURA) Earns Market Outperform Rating from JMP Securities - Defense World

May 25, 2025
pulisher
May 24, 2025

Northern Trust Corp Has $3.18 Million Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World

May 24, 2025
pulisher
May 23, 2025

JMP maintains $19 target on Aura Biosciences stock after FDA insights - Investing.com Canada

May 23, 2025
pulisher
May 23, 2025

AURA: JMP Securities Reiterates Market Outperform Rating | AURA Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Strategic Positioning and Regulatory Advantage Bolster Aura Biosciences Inc’s Buy Rating - TipRanks

May 23, 2025
pulisher
May 23, 2025

Finance Watch: Public Company Fundraising Sank Across The Board In Q1 - insights.citeline.com

May 23, 2025
pulisher
May 22, 2025

Anthony Gibney Buys 721% More Aura Biosciences Shares - simplywall.st

May 22, 2025
pulisher
May 21, 2025

Long Term Trading Analysis for (AURA) - news.stocktradersdaily.com

May 21, 2025
pulisher
May 20, 2025

Aura Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 20, 2025
pulisher
May 20, 2025

Major Stock Moves: Aura Biosciences Inc Sees Insider Buying Spree! - TipRanks

May 20, 2025
pulisher
May 19, 2025

Promising Developments and Strategic Advancements Propel Aura Biosciences Inc’s Buy Rating - TipRanks

May 19, 2025
pulisher
May 17, 2025

Aura Biosciences Advances in Cancer Therapy Trials - TipRanks

May 17, 2025
pulisher
May 16, 2025

Aura Biosciences Raises $69.9 Million in Public Offering - TipRanks

May 16, 2025
pulisher
May 16, 2025

Aura Biosciences announces public offering; shares down - MSN

May 16, 2025
pulisher
May 16, 2025

Aura Biosciences: Strategic Advancements and Clinical Progress Drive Buy Rating - TipRanks

May 16, 2025
pulisher
May 16, 2025

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval - Endpoints News

May 16, 2025
pulisher
May 16, 2025

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

May 16, 2025
pulisher
May 15, 2025

Aura Biosciences Launches Public Offering Of Common Stock And Warrants - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences announces common stock, warrant offering, no amount given - TipRanks

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Prices $75 Million Offering of Shares, Warrants - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences sets terms for $75 million public offering By Investing.com - Investing.com India

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences sets terms for $75 million public offering - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Secures $75M Funding: Major Push for Precision Cancer Treatment Development - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Aura Biosciences Launches Proposed Public Offering of Shares, Warrants - marketscreener.com

May 15, 2025

Finanzdaten der Aura Biosciences Inc-Aktie (AURA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aura Biosciences Inc-Aktie (AURA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Johnson David Michael
Director
May 16 '25
Buy
4.90
20,000
98,000
166,167
Gibney Anthony S
See Remarks
May 16 '25
Buy
4.90
50,000
245,000
58,452
Gibney Anthony S
See Remarks
May 16 '25
Sale
5.15
1,519
7,823
56,933
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):